Matthias Aizenberg

Matthias Aizenberg

Healthcare Innovation Consultant
Matthias Aizenberg is a seasoned expert in the Healthcare industry. He explores digital health, clinical processes, and healthcare management strategies. Matthias has a deep interest in pharmaceutical and healthcare innovation and is a well-trusted resource for biopharma professionals.
How Do PSMA Scans Reshape Prostate Cancer Care?
Research & Development How Do PSMA Scans Reshape Prostate Cancer Care?

For men who have undergone surgery to remove their prostate, a subsequent rise in a key blood marker often signals the cancer's return, plunging them into a period of clinical uncertainty where the next steps have historically been guided more by protocol than precision. This research summary

AI Stethoscope Doubles Detection of Serious Heart Disease
Tech & Innovation AI Stethoscope Doubles Detection of Serious Heart Disease

Today we're speaking with Ivan Kairatov, a biopharma expert with deep insights into the intersection of technology and clinical research. We'll be exploring a groundbreaking study on an AI-powered stethoscope that could fundamentally change how we screen for heart disease. Our discussion will cover

Can Safer mRNA Delivery Unlock a New Era of Medicine?
Biotech & Bioprocessing Can Safer mRNA Delivery Unlock a New Era of Medicine?

The immense success of messenger RNA vaccines painted a tantalizing picture of a medical revolution, yet the very technology that made them possible has also been a barrier to their wider therapeutic use. While transformative in preventing infectious diseases, the first generation of mRNA delivery

Cancer's Sticky Coat Key to Its Deadly Spread
Research & Development Cancer's Sticky Coat Key to Its Deadly Spread

A baffling contradiction has long stood at the heart of understanding how one of the most aggressive forms of breast cancer spreads throughout the body, but new research has finally unraveled this mystery, revealing a unique survival strategy that cancer cells use to become metastatic. For years,

Is a Crypto IPO the Future of Health Tech?
Tech & Innovation Is a Crypto IPO the Future of Health Tech?

The well-trodden path for ambitious tech companies seeking capital and public validation has long been the traditional initial public offering, but a new class of innovators is now charting a course that fuses the rigor of Wall Street with the disruptive potential of Web3. Mexico City-based

Mutation Quality, Not Quantity, Drives Cancer Therapy
Research & Development Mutation Quality, Not Quantity, Drives Cancer Therapy

The promise of harnessing the body's own immune system to fight cancer has been one of the most significant medical breakthroughs of the century, yet a persistent paradox has puzzled clinicians and researchers alike. For years, the prevailing wisdom held that tumors with more genetic mutations were

Why Is Context the Missing Link in Medical AI?
Tech & Innovation Why Is Context the Missing Link in Medical AI?

Thousands of medical artificial intelligence models demonstrate remarkable accuracy in laboratory settings, yet very few have successfully made the leap into the complex, dynamic environment of a real-world hospital. This persistent gap between potential and practice highlights a fundamental

How Does a Common Fungus Make Cancer More Deadly?
Research & Development How Does a Common Fungus Make Cancer More Deadly?

The microscopic world teeming within the human body harbors countless secrets, with recent discoveries now implicating a common fungus not as a mere passenger but as a sinister co-conspirator in the spread of deadly skin cancer. This revelation challenges conventional understanding by suggesting

Can Europe Deliver on Its Promise to Beat Cancer?
Tech & Innovation Can Europe Deliver on Its Promise to Beat Cancer?

The staggering reality of cancer in Europe continues to cast a long shadow, with over 3.2 million new diagnoses and 1.5 million lives lost each year, underscoring the urgent need for a unified and effective response. Amid this challenge, a powerful new paradigm in oncology has emerged, encapsulated

Is a Single Protein Key to Safer Radiotherapy?
Research & Development Is a Single Protein Key to Safer Radiotherapy?

The successful conclusion of cancer treatment should be a moment of pure triumph, yet for many, it signals the start of a lifelong struggle with chronic, painful tissue damage—a silent epidemic born from the very therapy that saved them. While radiotherapy stands as a pillar of modern oncology, its

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later